Investor Relations
Investor Relations Contact:
Anne Marie Fields
Bruce Voss

Media Contact
Rooney & Associates
Terry Rooney
Marion Janic

OPKO Health to Acquire Transition Therapeutics more »

FDA Approves New Drug Application for RAYALDEE® to Treat Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Stage 3-4 Chronic Kidney Disease more »

OPKO Health to Host Analyst & Investor Day in New York City on June 15 more »

OPKO Health Announces Move to NASDAQ Stock Market more »

Conferences & Events

Upcoming Events
Details on upcoming events are not yet available.

Archived Events
Jun 15, 2016
4:30 PM ET
OPKO Healths's Analyst and Investor Day
Webcast Listen to webcast
Jun 9, 2016
11:30 AM ET
2016 Jefferies Healthcare Conference
Webcast Listen to webcast
PDF View Presentation 887.0 KB
May 9, 2016
4:30 PM ET
OPKO First Quarter 2016 Financial Results
Webcast Listen to webcast
Mar 30, 2016
8:30 AM ET
OPKO Health Regulatory Update Conference Call
Webcast Listen to webcast
Feb 29, 2016
4:30 PM ET
OPKO Fourth Quarter and Full Year 2015 Financial Results
Webcast Listen to webcast

Email  Sign up for email alerts